Minocycline HCl Microspheres

DRUG5 trials

Sponsors

OraPharma, University of Minnesota

Conditions

BiomarkersMinocycline HCl MicrospheresPeri-ImplantitisPeriodontitisSRP

Phase 3

Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis

CompletedNCT00371332

OraPharmaPeriodontitis

Start: 2004-01-31Target: 128Updated: 2006-09-25

Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)

CompletedNCT01517334

OraPharmaPeri-Implantitis

Start: 2012-05-31End: 2014-11-30Updated: 2015-08-26

Arestin - Use in Subjects With Peri-Implantitis

CompletedNCT01539564

OraPharmaPeri-Implantitis

Start: 2012-04-30End: 2014-06-30Updated: 2014-06-26

Phase 4

Long-term Safety of Minocycline in Patients With Gum Disease

CompletedNCT00668746

OraPharmaPeriodontitis

Start: 2007-12-31End: 2009-02-28Updated: 2011-12-12

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

CompletedNCT03762915

University of MinnesotaBiomarkers, Minocycline HCl Microspheres, SRP

Start: 2019-05-20End: 2022-04-01Updated: 2025-01-28